Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 62% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18562911 | NOVEL UNIVERSAL ANTI-RNA VIRUS AGENTS | Non-Final OA | Emory University |
| 17584129 | METHODS AND THERAPIES FOR TREATING ATHEROSCLEROSIS AND/OR HYPERLIPIDEMIA USING OLIGOSACCHARIDES | Non-Final OA | The Regents of the University of California |
| 18449862 | PROCESS FOR THE DE-TRITYLATION OF OLIGONUCLEOTIDES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18567464 | METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY | Non-Final OA | Sol-Gel Technologies Ltd. |
| 18017297 | METHOD FOR MODULATING THE BLADDER MICROBIOME TO IMPROVE BLADDER HEALTH | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18343296 | METHOD FOR ISOLATING RNA WITH HIGH YIELD | Non-Final OA | QIAGEN GmbH |
| 18552615 | TREATMENT OF RNA VIRUS INFECTION WITH A CYTIDINE DEAMINASE INHIBITOR | Non-Final OA | The Cleveland Clinic Foundation |
| 18197402 | COMPOSITIONS AND METHODS THAT ATTENUATE COGNITIVE AGING IN INDIVIDUALS WHO DO NOT HAVE DEMENTIA | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18405347 | RESTORING PHYSIOLOGY WITH SMALL MOLECULE MIMICS OF MISSING PROTEINS | Non-Final OA | The Board of Trustees Of The University Of Illinois |
| 17904211 | LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING | Final Rejection | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 17923687 | METHOD FOR PURIFYING NUCLEIC ACID | Non-Final OA | SEKISUI CHEMICAL CO., LTD. |
| 18361713 | COMPOSITIONS AND METHODS FOR MAKING AND USING DOUBLE NETWORK HYDROGELS | Non-Final OA | The Regents of the University of Colorado, a Body Corporate |
| 17674177 | POLYNUCLEOTIDE CAPTURE MATERIALS, AND SYSTEMS USING SAME | Non-Final OA | HANDYLAB, INC. |
| 18883520 | TARGETED COMPOSITIONS | Non-Final OA | ARBUTUS BIOPHARMA CORPORATION |
| 17781963 | METHOD FOR PRODUCING CATIONIZED CELLULOSE AND CATIONIZED CELLULOSE | Non-Final OA | Kemira Oyj |
| 18252358 | NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE | Non-Final OA | DAIICHI SANKYO COMPANY, LIMITED |
| 18568968 | ANTIVIRAL NUCLEOSIDE ANALOGUES | Non-Final OA | Albert Einstein College of Medicine |
| 18479576 | 4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USE | Non-Final OA | Gilead Sciences, Inc. |
| 18319879 | BIOACTIVE PROCESS FOR BIOGENERATION OF FUNCTIONAL CARBOHYDRATES FROM DAIRY BY-PRODUCTS | Non-Final OA | The Royal Institution For The Advancement Of Learning/McGill University |
| 17755634 | CELLULOSE ESTERS COMPRISING RECYCLE CONTENT BUTYRYL | Non-Final OA | ExxonMobil Product Solutions Company |
| 18425427 | TRIPLE COMBINATION THERAPIES FOR ANTI-AGING | Non-Final OA | LUNELLA BIOTECH, INC. |
| 17997787 | METHOD FOR IDENTIFYING RNA BINDING PROTEIN BINDING SITES ON RNA | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18569494 | MANNO-OLIGOSACCHARIDE COMPOSITIONS FOR PATHOGEN CONTROL | Non-Final OA | GREENSAGE PREBIOTICS INC. |
| 18533937 | THERAPEUTIC AGENTS AND METHODS OF PRODUCING SAME | Non-Final OA | Glycosynnovations PTY LTD |
| 18560254 | MIXTURES OF POLYSACCHARIDES AND POLYAMINOSACCHARIDES WITH IMPROVED RHEOLOGICAL PROPERTIES | Non-Final OA | JOINTHERAPEUTICS S.R.L. |
| 18504922 | METHOD FOR INHIBITING BODY FAT ACCUMULATION AND METHOD FOR INHIBITING BODY WEIGHT GAIN | Non-Final OA | NAGAOKA CO., LTD. |
| 18288443 | Method for Purifying Sophorolipid | Non-Final OA | Macrocare Tech., Ltd. |
| 18287530 | NUTRITIONAL SUPPLEMENT AND USES | Non-Final OA | Citrox Biosciences Limited |
| 17915943 | PHARMACEUTICAL COMPOSITION COMPRISING GAMMA-CYCLODEXTRIN POLYMER AND USES THEREOF | Non-Final OA | RENATUS INC. |
| 18554006 | TREATMENT OF VIRUS INFECTIONS | Non-Final OA | TX MEDIC AB |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy